Pursuing Breakthrough Therapies for Rare Metabolic Diseases

A biotech organization focusing on gene therapies for metabolic diseases partnered with Veristat to support their Phase I/II clinical study for the treatment of a rare human genetic lysosomal storage disorder. Learn how Veristat’s Full-Service clinical trial team helped tightly coordinate a Gene Therapy’s dosing administration and data review.

download